CCSD code C6930 – Anterior chamber injection billing guide

Key takeaways

CCSD Code C6930 covers injection into the anterior chamber, and the anaesthetic is bundled into the fee rather than billed separately.

The most common clinical trigger is intracameral antibiotic prophylaxis, usually cefuroxime, given at cataract surgery.

Whether C6930 is separately payable alongside a phacoemulsification code varies by insurer, so verify the payer’s current schedule before submitting.

Practice management software like Pabau supports CCSD code lookup, insurer-specific rules, and audit-ready procedure notes for UK private practices.

CCSD Code C6930: definition and clinical scope

The CCSD Group defines CCSD Code C6930 as: Injection into anterior chamber (including topical or local anaesthetic). CCSD stands for Clinical Coding and Schedule Development. This group maintains the procedure code schedule used by UK private medical insurers, and its members are Bupa, AXA Health, Aviva and Vitality.

The code covers any injection delivered into the anterior segment of the eye, from the corneal limbus to the lens. It applies wherever topical anaesthesia or a local anaesthetic block prepares the eye.

C6930 sits within the ophthalmology chapter of the CCSD schedule, alongside corneal, lens and vitreoretinal procedure codes. Private ophthalmology practices meet it regularly on cataract lists, in anterior segment trauma cases, and in intracameral therapeutic procedures.

The code applies regardless of which substance is injected, provided the injection site is the anterior chamber. It does not extend to injections into the vitreous, the subconjunctival space, or periocular tissues. Each of those sites carries its own CCSD code.

What the anterior chamber injection procedure involves

Understanding the clinical steps helps billing staff document what the operative note must capture. A consultant ophthalmologist performs the procedure in four broad stages.

1. Patient preparation: The team instills topical anaesthetic drops, typically proxymetacaine or oxybuprocaine, into the eye. A local anaesthetic block around the globe replaces this where the planned procedure or the patient’s cooperation calls for it.
2. Wound entry: The surgeon makes a small paracentesis or limbal incision with a keratome or needle to access the anterior chamber.
3. Substance injection: The surgeon delivers the prepared agent, whether antibiotic, viscoelastic or anaesthetic solution, into the anterior chamber under controlled pressure. Volume is typically 0.1 ml for antibiotics. Viscoelastic agents used in surgical preparation take larger volumes.
4. Wound closure and post-procedure check: The entry site self-seals in most cases. Before the patient leaves the operating area, the team checks intraocular pressure and anterior chamber depth.

The procedure note must record each of these stages explicitly. Vague entries such as “intracameral injection given” are a leading cause of claim rejection by Bupa and AXA Health.

Anaesthesia inclusion: what the code bundles

The descriptor for CCSD Code C6930 states “including topical or local anaesthetic.” As a result, the procedure fee bundles the anaesthetic, so it must not appear as a separate line item.

Raising another anaesthetic code alongside C6930 counts as unbundling under the CCSD schedule. Most UK private medical insurers reject it outright. The bundling rule covers two anaesthetic types.

• Topical anaesthetic (surface anaesthesia): Drops instilled onto the cornea before needle entry. C6930 covers these regardless of the number of drops or the preparation used.
• Local anaesthetic injection: A peri- or retrobulbar block given before the intracameral injection. C6930 covers this too. The block does not generate a separate payable code when the primary procedure is an anterior chamber injection.

Insurer-specific exceptions may exist in each provider’s manual. Verify against the current schedule for each payer before assuming the bundling rule is absolute. Even so, the descriptor’s explicit inclusion wording makes separate billing hard to justify at audit.

Common clinical indications for an anterior chamber injection

Several distinct clinical scenarios generate a valid C6930 claim. The table below maps the most frequent indications to their supporting clinical authority and relevant ICD-10 context.

One principle runs across all these indications. The ICD-10 diagnosis code on the claim must support the clinical reason for the injection itself, as well as the main surgical procedure.

Billing CCSD Code C6930 alongside cataract surgery codes

Whether C6930 can be billed alongside a cataract code depends on the insurer. This is the most common co-billing question for the code, and the place where unbundling most often goes wrong.

Under CCSD schedule principles, you should not separately bill a procedure that forms an integral and routine part of another listed procedure. Intracameral cefuroxime is now standard practice at phacoemulsification in the UK. NICE guideline NG77 on managing cataracts in adults supports it, and the Royal College of Ophthalmologists endorses it.

Some insurers therefore treat C6930 as included within the phacoemulsification code. That applies when the injection is an antibiotic given at the same operating session.

Other insurers permit a separate C6930 claim when the operative note identifies the injection as a distinct clinical act. The note has to name its own indication, substance, and technique. How the note is written decides the outcome as often as what was done in theatre.

• Check each insurer’s current provider manual before appending C6930 to any cataract extraction or IOL implantation code.
• Confirm in the payer’s own code search whether C6930 carries a separate payment or is flagged as bundled alongside your primary code.
• Document the injection as a distinct operative step, with its own entry, substance, dose, and purpose. Any successful separate claim rests on that entry.
• Consultants moving from NHS work rarely meet this question, because HRG grouping logic handles bundling differently from a private insurer schedule.

Drugs and substances: what the code covers and what it does not

CCSD Code C6930 covers the act of injection into the anterior chamber. It does not automatically cover the cost of the drug or device used. Whether the substance requires a separate line item depends on the insurer and the type of agent.

Always verify per payer before adding a drug line. Submitting a drug charge that the insurer considers bundled within the procedure fee creates an overpayment risk at audit.

Neighbouring CCSD codes and how C6930 differs

The most frequent coding error on ophthalmic injection claims is applying the wrong injection site code. Unlike the vitreous, the subconjunctival space, and the periocular tissues, the anterior chamber sits in its own place. Misassigning the site triggers instant rejection from most insurers.

The CCSD procedure codes index lists the ophthalmology chapter in full, which is the quickest way to check a neighbouring code before you submit.

The operative note must name the injection site precisely. “Intracameral” or “into the anterior chamber” is the accepted language. Notes that describe the route as “intraocular” without naming the compartment are ambiguous and invite coding disputes.

Anterior segment injection claim denial: causes and how to appeal

Denied C6930 claims cluster around five root causes, each with a defined appeal pathway and most preventable with the right documentation at the time of the procedure.

1. Missing pre-authorisation: Several insurers require prior approval for C6930 when it isn’t billed alongside a pre-authorised cataract procedure, and submitting without it results in outright rejection. Appeal with the main procedure’s authorisation reference, plus evidence that C6930 was an expected adjunct.
2. Unbundling flag (anaesthetic): A second anaesthetic code appears on the same claim. Withdraw it and resubmit with a covering note citing the descriptor’s explicit inclusion wording.
3. Bundling with the primary procedure: The insurer’s schedule treats C6930 as integral to the main cataract code. Appeal with the operative note showing the injection as a distinct clinical act with its own precise indication, such as prophylactic antibiotic rather than surgical lubricant.
4. Insufficient medical necessity documentation: The operative note lacks a clear ICD-10 diagnosis code or a clinical rationale linking the injection to a recognised indication. Supplement the appeal with the procedure note, ICD-10 code, and a brief clinical letter from the consultant.
5. Wrong injection site code: The claim used an intravitreal or subconjunctival code instead of C6930, and the payer queried the mismatch. Correct it with an amended operative note confirming the anterior chamber as the injection site.

Appeals to UK insurers go through the insurer’s provider dispute portal, not the patient. Keep a copy of every operative note, consent form, and pre-authorisation reference on file.

Pre-authorisation requirements by insurer

Pre-authorisation requirements for C6930 differ widely between payers. The table below summarises the general position for four large UK private medical insurers, based on published provider guidance. Always verify against each insurer’s current provider manual before submitting, because these rules change.

Vitality also lists CCSD codes with their payment status in its fee-finder tool. Pre-authorisation requirements for adjunct codes like C6930 are worth confirming directly with the provider relations team. The same applies to Cigna UK and WPA for patients covered abroad.

Documentation that survives an insurer audit

A clean C6930 claim rests on the operative or procedure note. The note must contain six specific elements to withstand insurer scrutiny.

1. Injection site: Named explicitly as “anterior chamber” or “intracameral”, never as “intraocular” or “eye injection”.
2. Substance injected: Full drug name, formulation, and volume, for example “cefuroxime 1 mg/0.1 ml preservative-free solution”.
3. Anaesthesia method: Whether the team used topical drops or a local anaesthetic block, and which agent. This substantiates that the team administered the bundled anaesthetic properly.
4. Clinical indication: The reason for the injection in plain clinical language, supported by an ICD-10 diagnosis code on the claim form.
5. Operator: The name and GMC number of the consultant who performed the injection.
6. Date and side: Date of procedure and which eye. Bilateral procedures on the same date need separate notation for each eye.

Capturing all six at the point of care beats rebuilding them from theatre lists afterwards. Notes rebuilt later are a red flag at insurer audit and can lead to full claim recovery demands.

How Pabau supports CCSD ophthalmology billing

Most private ophthalmology practices keep the theatre note in one system and raise the invoice in another. The two systems reconcile only when a payer queries a line. Practice management software like Pabau lets UK practices look up CCSD codes and apply each insurer’s billing rules in the same place.

You can build procedure note templates to prompt for the six-element standard described above. Pabau’s audit-ready claims management then links the procedure record to the invoiced code.

That ties the clinical note, the code, and the payment together in one place. It matters most on high-volume cataract lists, where practices routinely append C6930 and insurer checks are common.

The Bupa CCSD procedure codes guide covers the wider CCSD billing framework, including the ophthalmology chapter codes that sit around C6930.

Manage CCSD billing without the admin overhead

Pabau’s claims management tools help UK private practices look up CCSD codes, track insurer-specific rules, and keep procedure notes audit-ready. See how it works for ophthalmology practices.

Book a demo

Conclusion

CCSD Code C6930 has a tight descriptor, but insurer-by-insurer rules set its billing behaviour on bundling, pre-authorisation, and drug cost recovery. The anaesthetic is always bundled. Whether the code and the drug are separately payable alongside a cataract code is a payer-specific question, so verify it before submission.

The leverage therefore sits in theatre rather than in the appeal. A note that already names site, substance, volume, anaesthesia, indication, operator, and laterality turns most denials into a resend.

Book a demo to see how Pabau keeps CCSD codes, procedure notes, and insurer rules together for your ophthalmology lists.

Continue your research

Billing Bupa as a private consultant? Bupa CCSD codes and fee schedule guide covers the full CCSD code family for Bupa-insured patients, including ophthalmology chapter codes.

Managing multiple insurers across a private practice? Pabau’s claims management software centralises CCSD code billing, insurer rules, and payment tracking in one place.

Choosing billing software for a UK private practice? Best medical billing software in the UK compares the platforms that handle CCSD coding and insurer submissions.

Frequently asked questions